Literature DB >> 11752529

Long-term treatment of patients affected by systemic sclerosis with cyclosporin A.

G Filaci, M Cutolo, M Basso, G Murdaca, L Derchi, R Gianrossi, F Ropolo, P Zentilin, A Sulli, F Puppo, F Indiveri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11752529     DOI： 10.1093/rheumatology/40.12.1431

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  15 in total

Review 1.  Immunomodulatory therapy for SSc: will high-intensity immunosuppression with stem cell rescue improve outcome?

Authors:  Leslie J Crofford
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 2.  Recent advances in the treatment of systemic sclerosis.

Authors:  Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

3.  Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.

Authors:  Mehdi Mohamadnejad; Reza Malekzadeh; Siavosh Nasseri-Moghaddam; Sepideh Hagh-Azali; Nasser Rakhshani; Seyed Mohamad Tavangar; Mojtaba Sedaghat; Seyed Meysam Alimohamadi
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  Clinical trials for pediatric scleroderma.

Authors:  Margalit E Rosenkranz; Thomas J A Lehman
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 5.  Scleroderma therapy: clinical overview of current trends and future perspective.

Authors:  Afsha A Topal; Rachita S Dhurat
Journal:  Rheumatol Int       Date:  2012-08-03       Impact factor: 2.631

Review 6.  Assessing microvascular changes in systemic sclerosis diagnosis and management.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

Review 7.  Systemic and localized scleroderma in children: current and future treatment options.

Authors:  Margalit E Rosenkranz; Lucila M A Agle; Petros Efthimiou; Thomas J A Lehman
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 8.  Nailfold capillaroscopy in systemic sclerosis - state of the art: The evolving knowledge about capillaroscopic abnormalities in systemic sclerosis.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  J Scleroderma Relat Disord       Date:  2019-04-15

9.  Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A.

Authors:  Wei-Sheng Chen; An-Hang Young; Hon-Pin Wang; De-Feng Huang
Journal:  Rheumatol Int       Date:  2009-01-21       Impact factor: 2.631

Review 10.  The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.